TreeWAS – Variant ID: rs2442825

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S02.10 Fracture of base of skull (closed)	0.022	0.978	0.000
S02.1 Fracture of base of skull	0.017	0.983	0.000
C77.4 Inguinal and lower limb lymph nodes	0.016	0.984	0.000
M25.46 Effusion of joint (Lower leg)	0.000	0.984	0.016
H40.0 Glaucoma suspect	0.000	0.985	0.015
S02.20 Fracture of nasal bones (closed)	0.015	0.985	0.000
S02.2 Fracture of nasal bones	0.014	0.986	0.000
M17.9 Gonarthrosis, unspecified	0.000	0.987	0.013
K50.8 Other Crohn's disease	0.013	0.987	0.000
S02 Fracture of skull and facial bones	0.013	0.987	0.000
S02.11 Fracture of base of skull (open)	0.013	0.987	0.000
S02.0 Fracture of vault of skull	0.012	0.988	0.000
S02.21 Fracture of nasal bones (open)	0.012	0.988	0.000
S02.00 Fracture of vault of skull (closed)	0.011	0.989	0.000
S02.8 Fractures of other skull and facial bones	0.011	0.989	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.010	0.990	0.000
L81.4 Other melanin hyperpigmentation	0.009	0.991	0.000
S02.3 Fracture of orbital floor	0.009	0.991	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.991	0.009
S02.01 Fracture of vault of skull (open)	0.009	0.991	0.000
S02.7 Multiple fractures involving skull and facial bones	0.009	0.991	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.009	0.991	0.000
S02.81 Fractures of other skull and facial bones (open)	0.008	0.992	0.000
D46 Myelodysplastic syndromes	0.000	0.992	0.008
S02.5 Fracture of tooth	0.007	0.993	0.000
K50 Crohn's disease [regional enteritis]	0.007	0.993	0.000
M19.98 Arthrosis, unspecified (Other)	0.000	0.993	0.007
D46.7 Other myelodysplastic syndromes	0.000	0.993	0.007
S02.31 Fracture of orbital floor (open)	0.007	0.993	0.000
S02.4 Fracture of malar and maxillary bones	0.007	0.993	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.007	0.993	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.006	0.993	0.000
S02.6 Fracture of mandible	0.006	0.993	0.001
D46.4 Refractory anaemia, unspecified	0.000	0.993	0.007
S02.30 Fracture of orbital floor (closed)	0.006	0.993	0.000
D46.1 Refractory anaemia with sideroblasts	0.000	0.994	0.006
D46.2 Refractory anaemia with excess of blasts	0.000	0.994	0.006
S02.70 Multiple fractures involving skull and facial bones (closed)	0.006	0.994	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.006	0.994	0.000
L81 Other disorders of pigmentation	0.006	0.994	0.000
M95.0 Acquired deformity of nose	0.000	0.994	0.006
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.000	0.994	0.006
D46.5 Refractory anaemia with multi-lineage dysplasia	0.000	0.994	0.006
D46.3 Refractory anaemia with excess of blasts with transformation	0.000	0.994	0.006
D46.0 Refractory anaemia without sideroblasts, so stated	0.000	0.994	0.006
L81.9 Disorder of pigmentation, unspecified	0.006	0.994	0.000
K50.9 Crohn's disease, unspecified	0.006	0.994	0.000
Y85.0 Sequelae of motor-vehicle accident	0.006	0.994	0.000
S02.51 Fracture of tooth (open)	0.005	0.994	0.000
K50.0 Crohn's disease of small intestine	0.005	0.995	0.000
K26.4 Chronic or unspecified with haemorrhage	0.000	0.995	0.005
K50.1 Crohn's disease of large intestine	0.005	0.995	0.000
D47.1 Chronic myeloproliferative disease	0.000	0.995	0.005
K26.3 Acute without haemorrhage or perforation	0.000	0.995	0.005
F20.9 Schizophrenia, unspecified	0.005	0.995	0.000
L81.8 Other specified disorders of pigmentation	0.005	0.995	0.000
K26.5 Chronic or unspecified with perforation	0.000	0.995	0.005
S02.41 Fracture of malar and maxillary bones (open)	0.005	0.995	0.000
S02.61 Fracture of mandible (open)	0.004	0.995	0.001
K26 Duodenal ulcer	0.000	0.995	0.005
F20 Schizophrenia	0.005	0.995	0.000
F20.5 Residual schizophrenia	0.005	0.995	0.000
L81.7 Pigmented purpuric dermatosis	0.004	0.995	0.000
L81.6 Other disorders of diminished melanin formation	0.004	0.995	0.000
L81.5 Leukoderma, not elsewhere classified	0.004	0.995	0.000
L81.3 Cafe au lait spots	0.004	0.995	0.000
L81.1 Chloasma	0.004	0.995	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
F20.0 Paranoid schizophrenia	0.004	0.996	0.000
L81.0 Postinflammatory hyperpigmentation	0.004	0.996	0.000
Z36.8 Other antenatal screening	0.000	0.996	0.004
M19.93 Arthrosis, unspecified (Forearm)	0.004	0.996	0.000
K26.2 Acute with both haemorrhage and perforation	0.000	0.996	0.004
K26.0 Acute with haemorrhage	0.000	0.996	0.004
T39.0 Salicylates	0.004	0.996	0.000
D25.1 Intramural leiomyoma of uterus	0.004	0.996	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.996	0.004
L81.2 Freckles	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
F20.8 Other schizophrenia	0.003	0.996	0.000
F20.6 Simple schizophrenia	0.003	0.996	0.000
F20.4 Postschizophrenic depression	0.003	0.996	0.000
F20.3 Undifferentiated schizophrenia	0.003	0.996	0.000
F20.1 Hebephrenic schizophrenia	0.003	0.996	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
K26.1 Acute with perforation	0.000	0.996	0.004
T21.0 Burn of unspecified degree of trunk	0.000	0.996	0.004
F20.2 Catatonic schizophrenia	0.003	0.996	0.000
H40.4 Glaucoma secondary to eye inflammation	0.000	0.996	0.004
D47.4 Osteomyelofibrosis	0.000	0.996	0.003
D47.2 Monoclonal gammopathy	0.000	0.996	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.000	0.997	0.003
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.000	0.997	0.003
H40 Glaucoma	0.000	0.997	0.003
D45 Polycythaemia vera	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
Z45.1 Adjustment and management of infusion pump	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
D37.4 Colon	0.000	0.997	0.003
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.997	0.003
M17.0 Primary gonarthrosis, bilateral	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
S02.50 Fracture of tooth (closed)	0.003	0.997	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.997	0.003
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
N04.9 Unspecified	0.000	0.997	0.003
H40.8 Other glaucoma	0.000	0.997	0.003
J36 Peritonsillar abscess	0.003	0.997	0.000
G70.0 Myasthenia gravis	0.003	0.997	0.000
M17 Gonarthrosis [arthrosis of knee]	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
M95.2 Other acquired deformity of head	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T21 Burn and corrosion of trunk	0.000	0.997	0.003
D03.4 Melanoma in situ of scalp and neck	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T21.3 Burn of third degree of trunk	0.000	0.997	0.003
O00.9 Ectopic pregnancy, unspecified	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T21.2 Burn of second degree of trunk	0.000	0.997	0.003
D37.1 Stomach	0.000	0.997	0.003
H40.6 Glaucoma secondary to drugs	0.000	0.997	0.003
Z48.9 Surgical follow-up care, unspecified	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
M95.3 Acquired deformity of neck	0.000	0.997	0.003
X60.8 Other specified place	0.003	0.997	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.997	0.003
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.000	0.997	0.002
M95.8 Other specified acquired deformities of musculoskeletal system	0.000	0.997	0.002
M95.5 Acquired deformity of pelvis	0.000	0.997	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.997	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.997	0.003
T50.8 Diagnostic agents	0.002	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.002	0.997	0.000
T39.2 Pyrazolone derivatives	0.002	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.997	0.000
I89.0 Lymphoedema, not elsewhere classified	0.003	0.997	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.000	0.997	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.002	0.998	0.000
T21.1 Burn of first degree of trunk	0.000	0.998	0.002
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
S02.60 Fracture of mandible (closed)	0.001	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
T21.7 Corrosion of third degree of trunk	0.000	0.998	0.002
T21.6 Corrosion of second degree of trunk	0.000	0.998	0.002
T21.5 Corrosion of first degree of trunk	0.000	0.998	0.002
T21.4 Corrosion of unspecified degree of trunk	0.000	0.998	0.002
M95.1 Cauliflower ear	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
H40.3 Glaucoma secondary to eye trauma	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.998	0.002
E89.2 Postprocedural hypoparathyroidism	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
M95.4 Acquired deformity of chest and rib	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
K26.7 Chronic without haemorrhage or perforation	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.002	0.998	0.000
M17.3 Other posttraumatic gonarthrosis	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.000	0.998	0.002
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.002	0.998	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.000	0.998	0.002
M95.96 Acquired deformity of musculoskeletal system, unspecified	0.000	0.998	0.002
D39.0 Uterus	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
H40.9 Glaucoma, unspecified	0.000	0.998	0.002
H40.5 Glaucoma secondary to other eye disorders	0.000	0.998	0.002
I69.3 Sequelae of cerebral infarction	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
Q66.8 Other congenital deformities of feet	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
D42.9 Meninges, unspecified	0.000	0.998	0.002
D42.1 Spinal meninges	0.000	0.998	0.002
D42.0 Cerebral meninges	0.000	0.998	0.002
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.998	0.002
X60.5 Trade and service area	0.002	0.998	0.000
M25.86 Other specified joint disorders (Lower leg)	0.000	0.998	0.002
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.000	0.998	0.002
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.000	0.998	0.002
D44.1 Adrenal gland	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
N04 Nephrotic syndrome	0.000	0.998	0.002
R40.0 Somnolence	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
K44.0 Diaphragmatic hernia with obstruction, without gangrene	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
Z34.8 Supervision of other normal pregnancy	0.002	0.998	0.000
Y85 Sequelae of transport accidents	0.002	0.998	0.000
D37.5 Rectum	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
G63.2 Diabetic polyneuropathy	0.000	0.998	0.002
Q66 Congenital deformities of feet	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
D40.0 Prostate	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
X61.4 Street and highway	0.002	0.998	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.002	0.998	0.000
D39.9 Female genital organ, unspecified	0.000	0.998	0.002
D39.2 Placenta	0.000	0.998	0.002
D40.9 Male genital organ, unspecified	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
D03 Melanoma in situ	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.000	0.998	0.002
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.002	0.998	0.000
D40.7 Other male genital organs	0.000	0.998	0.002
D44.6 Carotid body	0.000	0.998	0.002
N04.1 Focal and segmental glomerular lesions	0.000	0.998	0.002
M17.5 Other secondary gonarthrosis	0.000	0.998	0.002
G70 Myasthenia gravis and other myoneural disorders	0.002	0.998	0.000
D38.0 Larynx	0.000	0.998	0.002
D39.7 Other female genital organs	0.000	0.998	0.002
Q66.9 Congenital deformity of feet, unspecified	0.002	0.998	0.000
Q66.6 Other congenital valgus deformities of feet	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.002	0.998	0.000
T79.7 Traumatic subcutaneous emphysema	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
D03.5 Melanoma in situ of trunk	0.002	0.998	0.000
O71.4 Obstetric high vaginal laceration alone	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.002	0.998	0.000
D38.6 Respiratory organ, unspecified	0.000	0.998	0.002
D38.4 Thymus	0.000	0.998	0.002
D38.3 Mediastinum	0.000	0.998	0.002
D38.2 Pleura	0.000	0.998	0.002
D44.9 Endocrine gland, unspecified	0.000	0.998	0.002
D44.5 Pineal gland	0.000	0.998	0.002
D44.2 Parathyroid gland	0.000	0.998	0.002
I82.2 Embolism and thrombosis of vena cava	0.000	0.998	0.002
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
N04.6 Dense deposit disease	0.000	0.998	0.002
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.998	0.002
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.998	0.002
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.998	0.002
T36.3 Macrolides	0.001	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
D03.8 Melanoma in situ of other sites	0.002	0.998	0.000
G91.1 Obstructive hydrocephalus	0.002	0.998	0.000
Q66.7 Pes cavus	0.002	0.998	0.000
Q66.2 Metatarsus varus	0.002	0.998	0.000
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
X60.09 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics; Home; During unspecified activity	0.001	0.998	0.000
X60.08 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Home , While engaged in other specified activities	0.001	0.998	0.000
X60.99 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Unspecified place, During unspecified activity	0.001	0.998	0.000
G70.9 Myoneural disorder, unspecified	0.002	0.998	0.000
D44.0 Thyroid gland	0.000	0.998	0.001
R09.2 Respiratory arrest	0.000	0.998	0.002
R10.2 Pelvic and perineal pain	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
D03.0 Melanoma in situ of lip	0.002	0.998	0.000
Q66.5 Congenital pes planus	0.001	0.998	0.000
Q66.4 Talipes calcaneovalgus	0.001	0.998	0.000
Q66.1 Talipes calcaneovarus	0.001	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.001	0.998	0.000
T42.3 Barbiturates	0.001	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.001	0.998	0.000
N04.8 Other	0.000	0.998	0.001
R49.0 Dysphonia	0.000	0.998	0.002
M81.40 Drug-induced osteoporosis (Multiple sites)	0.002	0.998	0.000
D03.9 Melanoma in situ, unspecified	0.001	0.998	0.000
N04.0 Minor glomerular abnormality	0.000	0.998	0.001
Q66.0 Talipes equinovarus	0.001	0.998	0.000
S81.0 Open wound of knee	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.001	0.998	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
M15.1 Heberden's nodes (with arthropathy)	0.000	0.998	0.002
X61.9 Unspecified place	0.001	0.998	0.000
X61.8 Other specified place	0.001	0.998	0.000
X61.0 Home	0.001	0.998	0.000
X61.7 Farm	0.001	0.998	0.000
X61.6 Industrial and construction area	0.001	0.998	0.000
X61.5 Trade and service area	0.001	0.998	0.000
X61.3 Sports and athletics area	0.001	0.998	0.000
X61.1 Residential institution	0.001	0.998	0.000
X64.2 School, other institution and public administrative area	0.001	0.998	0.000
X84.9 Unspecified place	0.001	0.998	0.000
D40.1 Testis	0.000	0.998	0.001
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.002	0.998	0.000
G70.8 Other specified myoneural disorders	0.001	0.998	0.000
G70.2 Congenital and developmental myasthenia	0.001	0.998	0.000
G70.1 Toxic myoneural disorders	0.001	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.998	0.002
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.998	0.002
Q78.0 Osteogenesis imperfecta	0.001	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.001	0.998	0.000
D37.9 Digestive organ, unspecified	0.000	0.998	0.001
D44.3 Pituitary gland	0.000	0.998	0.001
Q66.3 Other congenital varus deformities of feet	0.001	0.998	0.000
X62.8 Other specified place	0.001	0.998	0.000
E89.4 Postprocedural ovarian failure	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
T46.7 Peripheral vasodilators	0.001	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
D44.8 Pluriglandular involvement	0.000	0.998	0.001
D44.7 Aortic body and other paraganglia	0.000	0.998	0.001
T40.1 Heroin	0.001	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
X63.9 Unspecified place	0.001	0.998	0.000
X63.8 Other specified place	0.001	0.998	0.000
X63.7 Farm	0.001	0.998	0.000
X63.6 Industrial and construction area	0.001	0.998	0.000
X63.5 Trade and service area	0.001	0.998	0.000
X63.4 Street and highway	0.001	0.998	0.000
X63.3 Sports and athletics area	0.001	0.998	0.000
X63.2 School, other institution and public administrative area	0.001	0.998	0.000
X63.1 Residential institution	0.001	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.998	0.000
X79 Intentional self-harm by blunt object	0.001	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.998	0.000
X75 Intentional self-harm by explosive material	0.001	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.998	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.001	0.998	0.000
T36.0 Penicillins	0.001	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.998	0.000
T40.8 Lysergide [LSD]	0.001	0.998	0.000
T40.7 Cannabis (derivatives)	0.001	0.998	0.000
T40.3 Methadone	0.001	0.998	0.000
T40.0 Opium	0.001	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.001	0.998	0.000
H40-H42 Glaucoma	0.000	0.998	0.001
D37.3 Appendix	0.000	0.998	0.001
S63.6 Sprain and strain of finger(s)	0.001	0.998	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.001	0.999	0.000
D38.5 Other respiratory organs	0.000	0.999	0.001
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.001	0.999	0.000
K29.2 Alcoholic gastritis	0.001	0.999	0.000
T40.4 Other synthetic narcotics	0.001	0.999	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.001	0.999	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.999	0.001
X83 Intentional self-harm by other specified means	0.001	0.999	0.000
H16.0 Corneal ulcer	0.001	0.999	0.000
I82.8 Embolism and thrombosis of other specified veins	0.000	0.999	0.001
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.999	0.001
X64.9 Unspecified place	0.001	0.999	0.000
X64.0 Home	0.001	0.999	0.000
X64.8 Other specified place	0.001	0.999	0.000
X64.7 Farm	0.001	0.999	0.000
X64.6 Industrial and construction area	0.001	0.999	0.000
X64.5 Trade and service area	0.001	0.999	0.000
X64.4 Street and highway	0.001	0.999	0.000
X64.3 Sports and athletics area	0.001	0.999	0.000
X64.1 Residential institution	0.001	0.999	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.999	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.999	0.001
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.001	0.999	0.000
X65.8 Other specified place	0.001	0.999	0.000
X84.8 Other specified place	0.001	0.999	0.000
X84.7 Farm	0.001	0.999	0.000
X84.6 Industrial and construction area	0.001	0.999	0.000
X84.5 Trade and service area	0.001	0.999	0.000
X84.4 Street and highway	0.001	0.999	0.000
X84.3 Sports and athletics area	0.001	0.999	0.000
X84.2 School, other institution and public administrative area	0.001	0.999	0.000
X84.1 Residential institution	0.001	0.999	0.000
X84.0 Home	0.001	0.999	0.000
D37.7 Other digestive organs	0.000	0.999	0.001
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.001	0.999	0.000
H40.1 Primary open-angle glaucoma	0.000	0.999	0.001
I89.1 Lymphangitis	0.001	0.999	0.000
O90.2 Haematoma of obstetric wound	0.000	0.999	0.001
X62.0 Home	0.001	0.999	0.000
X62.7 Farm	0.001	0.999	0.000
X62.6 Industrial and construction area	0.001	0.999	0.000
X62.5 Trade and service area	0.001	0.999	0.000
X62.4 Street and highway	0.001	0.999	0.000
X62.3 Sports and athletics area	0.001	0.999	0.000
X62.2 School, other institution and public administrative area	0.001	0.999	0.000
X62.1 Residential institution	0.001	0.999	0.000
X61.09 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, Home , During unspecified activity	0.001	0.999	0.000
X61.08 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified; Home; While engaged in other specified activit	0.001	0.999	0.000
X61.88 Intentional self-poisoning by and exposure to antiepileptic,sedative-hypnotic,antiparkinsonism and psychotropic drugs,not elsewhere classified.Place/activity:other specified	0.001	0.999	0.000
X61.99 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, Unspecified place, During unspecified activity	0.001	0.999	0.000
X61.98 Intentional self-poisoning by and exposure to antiepileptic,sedative-hypnotic,antiparkinsonism and psychotropic drugs,not elsewhere classified.Unspecified place.Other specified activities.	0.001	0.999	0.000
L73.9 Follicular disorder, unspecified	0.000	0.999	0.001
M15.8 Other polyarthrosis	0.000	0.999	0.001
M15.2 Bouchard's nodes (with arthropathy)	0.000	0.999	0.001
T40.6 Other and unspecified narcotics	0.001	0.999	0.000
T40.5 Cocaine	0.001	0.999	0.000
X78 Intentional self-harm by sharp object	0.001	0.999	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.001	0.999	0.000
D38.1 Trachea, bronchus and lung	0.000	0.999	0.001
H27.8 Other specified disorders of lens	0.000	0.999	0.001
X65.9 Unspecified place	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations